The a2 Milk Company (ATM) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
16 Jun, 2026Executive summary
Achieved strong revenue and EBITDA growth in the first half, with underlying EBITDA margin improvement and upgraded full-year FY26 guidance, driven by robust performance across all segments and products.
Growth was led by core products, innovation, and strong performance in China, Asia, ANZ, and US markets, with Infant Milk Formula sales up 13.6% (English label up 20.9%, China label up 6.5%), Other Nutritionals up 42.9%, and Liquid Milk up 18.5%.
Completed major supply chain transformation: acquired a2 Pokeno, divested Mataura Valley Milk, and secured a long-term supply agreement with Fonterra.
Declared an interim dividend of 11.5 cents per share (~74% NPAT payout) and announced intention for a NZD 300 million special dividend, pending regulatory approval.
On track to reach $2 billion medium-term sales ambition in FY26, a year ahead of plan.
Financial highlights
Net sales revenue of $993.5 million, up 18.8% year-over-year; EBITDA up 18.4% to $155.0 million; underlying EBITDA up 25.9% to $164.8 million.
Net profit after tax up 9.4% to $112.1 million; underlying NPAT up 19.6% to $122.6 million.
Basic EPS up 9.2% to 15.5 cents; underlying EPS up 19.4% to 16.9 cents.
Gross margin at 48.9%, down 1.1pp due to a2 Pokeno losses; excluding these, gross margin slightly up.
Closing cash balance of $896.9 million, with operating cash conversion at 90.8%.
Outlook and guidance
Upgraded FY26 revenue growth guidance to mid double-digit percent (from low double-digit), with EBITDA margin range tightened to 15.5%-16%.
Net profit after tax expected to be up on FY25 reported; cash conversion of ~80%; capital expenditure of $60–$80 million.
On track to achieve $2 billion revenue in FY26, a year ahead of amended plan.
Guidance assumes adequate supply from Synlait and no major disruptions at a2 Pokeno.
Board intends to declare a $300 million special dividend, subject to regulatory approvals for a2 Pokeno China label registration amendments.
Latest events from The a2 Milk Company
- Strong FY24 growth with China IMF gains and supply chain improvements; FY25 outlook steady.ATM
H2 202416 Jun 2026 - Upgraded FY25 outlook, record China IMF share, and first-ever dividend highlight strong 1H25.ATM
H1 202516 Jun 2026 - Record sales, China growth, supply chain overhaul, and $300M special dividend planned.ATM
H2 202516 Jun 2026 - Strong FY24 results, new dividend policy, and China-focused strategy drive outlook.ATM
AGM 202412 Jan 2026 - Record sales, supply chain transformation, and a $300M special dividend headline the AGM.ATM
AGM 202520 Nov 2025